240 related articles for article (PubMed ID: 36443301)
1. mTORC1 links pathology in experimental models of Still's disease and macrophage activation syndrome.
Huang Z; You X; Chen L; Du Y; Brodeur K; Jee H; Wang Q; Linder G; Darbousset R; Cunin P; Chang MH; Wactor A; Wauford BM; Todd MJC; Wei K; Li Y; Levescot A; Iwakura Y; Pascual V; Baldwin NE; Quartier P; Li T; Gianatasio MT; Hasserjian RP; Henderson LA; Sykes DB; Mellins ED; Canna SW; Charles JF; Nigrovic PA; Lee PY
Nat Commun; 2022 Nov; 13(1):6915. PubMed ID: 36443301
[TBL] [Abstract][Full Text] [Related]
2. Recent advances and evolving concepts in Still's disease.
Ruscitti P; Cantarini L; Nigrovic PA; McGonagle D; Giacomelli R
Nat Rev Rheumatol; 2024 Feb; 20(2):116-132. PubMed ID: 38212542
[TBL] [Abstract][Full Text] [Related]
3. Adult-onset Still's disease complicated by macrophage activation syndrome during pregnancy: a case-based review.
Wise L; Zell M
Clin Rheumatol; 2023 Nov; 42(11):3159-3166. PubMed ID: 37322269
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
[TBL] [Abstract][Full Text] [Related]
5. [Still's syndrome-similarities and differences between the juvenile and adult forms].
Regel A; Föll D; Kriegel MA
Z Rheumatol; 2022 Feb; 81(1):22-27. PubMed ID: 34735597
[TBL] [Abstract][Full Text] [Related]
6. Macrophage Activation Syndrome Associated With Adult Onset Still's Disease.
Gulzar M; Sabir A; Hamdani MA; Saadia A
J Ayub Med Coll Abbottabad; 2018; 30(2):289-292. PubMed ID: 29938438
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
8. [Still's disease as biphasic disorder : Current knowledge on pathogenesis and novel treatment approaches].
Föll D; Wittkowski H; Hinze C
Z Rheumatol; 2020 Sep; 79(7):639-648. PubMed ID: 32253510
[TBL] [Abstract][Full Text] [Related]
9. Adult-onset Still's disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report.
Mimura T; Shimodaira M; Kibata M; Tsukadaira A; Shirahata K
BMC Res Notes; 2014 Dec; 7():940. PubMed ID: 25532568
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of MS-Score and HScore in timeliness of diagnosis of macrophage activation syndrome associated with adult-onset Still's disease].
Peng Z; Gao XM; Zhou S; Wu CY; Zhao JL; Xu D; Li MT; Peng JM; Li J; Wang Q; Tian XF; Zeng X
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2210-2214. PubMed ID: 35872586
[TBL] [Abstract][Full Text] [Related]
12. Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis.
Félix FH; Leal LK; Fontenele JB
Rheumatol Int; 2009 Jun; 29(8):973-4. PubMed ID: 19115058
[TBL] [Abstract][Full Text] [Related]
13. Application of MS score in macrophage activation syndrome patients associated with adult onset Still's disease.
Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; Bao C; Fu Q
Ann Rheum Dis; 2021 Sep; 80(9):e145. PubMed ID: 31611222
[No Abstract] [Full Text] [Related]
14. Response to 'Application of MS score in macrophage activation syndrome patients associated with adult onset Still's disease' by Wang
Minoia F; Ravelli A
Ann Rheum Dis; 2021 Sep; 80(9):e146. PubMed ID: 31653650
[No Abstract] [Full Text] [Related]
15. Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra.
Kumar A; Kato H
Case Rep Rheumatol; 2016; 2016():3717392. PubMed ID: 27818826
[TBL] [Abstract][Full Text] [Related]
16. mTORC1 implicated in Still's disease and MAS.
Onuora S
Nat Rev Rheumatol; 2023 Feb; 19(2):64. PubMed ID: 36609688
[No Abstract] [Full Text] [Related]
17. Macrophage activation syndrome and cytokine-directed therapies.
Schulert GS; Grom AA
Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):277-92. PubMed ID: 24974063
[TBL] [Abstract][Full Text] [Related]
18. [Multi-organ failure as first clinical sign of macrophage activation syndrome in childhood Still's disease].
López-Sánchez M; Rubio-López I; Obeso-González T; Teja-Barbero JL; Santidrián-Miguel JP; Peiro-Callizo E
An Pediatr (Barc); 2010 Oct; 73(4):194-8. PubMed ID: 20643591
[TBL] [Abstract][Full Text] [Related]
19. Response to: 'Comparison of MS score and HScore for the diagnosis of adult-onset Still's disease associated macrophage activation syndrome' by Zhang
Minoia F; Ravelli A
Ann Rheum Dis; 2022 Jun; 81(6):e100. PubMed ID: 32611601
[No Abstract] [Full Text] [Related]
20. Hemophagocytic Lymphohistiocytosis Secondary to Adult-Onset Still's Disease.
Barman B; Jamil M; Kalita P; Dey B
Cureus; 2021 Sep; 13(9):e18037. PubMed ID: 34671525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
